Background-Familial
hypertrophic cardiomyopathy is the most common inherited cardiac disorder, with sudden cardiac death at a young age the most frequent cause of death in affected individuals. Some cases of familial hypertrophic cardiomyopathy are caused by missense mutations of the p myosin heavy chain (p MHC) gene on chromosome 14 and at least 17 such mutations have been described. Recent reports suggest that a correlation exists between a specific fp MHC gene mutation and prognosis in familial hypertrophic cardiomyopathy. This premise is currently being used as a basis to provide counselling for affected families. This mutation/prognosis association, however, has not been widely assessed as yet. The clinical and prognostic features of two South African families of mixed racial descent, in which different p1 MHC gene mutations were segregating, were studied to evaluate this correlation. The results were compared with those of previously published reports of European families carrying the same mutations.
Methods-The pl MHC gene missense mutations in two affected families were identified by single strand conformation polymorphism analysis and sequencing (pedigree 106: Arg403Trp; pedigree 108: Arg249Gln). All family members were subjected to genotypic analysis using polymerase chain reaction amplification and restriction enzyme based mutation detection techniques. Clinical, electrocardiographic, and echocardiographic studies were performed on genotypically affected individuals in these two kindreds. Results-The number of individuals identified in pedigree 106 with the Arg403Trp mutation was 32. 10 individuals bore the Arg249Gln mutation in pedigree 108. The penetrance rate in adults (equal to or greater than 16 years), using the strict echocardiographic criterion of maximum left ventricular wall thickness > 13 mm, was 25% for pedigree 106 19 20) followed by single strand conformation polymorphism (SSCP) analysis.
Exons 9 and 13 were PCR amplified using the following primer pairs which were designed with the aid of the OLIGO and PRIMER computer programmes using published /3 MHC gene sequences28: Exon Each dialysed sample was digested with 4 U of the appropriate enzyme (Ava 1 in the case of the Arg4O3Trp mutation, and Taq 1 in the case of the Arg249Gln mutation) in the manufacturer's buffer (Promega) in a final volume of 10 ,ul (30 ,ul for the paraffin embedded tissue sample). Digestion was performed for 2 h at 37°C (Ava 1) and 65°C (Taq 1) and digested samples were subjected to electrophoresis on 12% polyacrylamide gels in 1 x TBE running buffer at 10 V/cm for 1.5 h. The DNA fragments were visualised under ultraviolet light after ethidium bromide staining of the gels.
Genotypes were determined from the gels according to the following patterns: The 150 bp amplified exon 13 fragment was digested into a 100 bp and a 50 bp fragment by Ava 1 in genotypically unaffected individuals. The C to T transition responsible for the Arg4O3Trp mutation destroyed this restriction enzyme site. Therefore, the presence of the Arg4O3Trp mutation in a heterozygous individual resulted in an additional uncut 150 bp fragment.
The 109 bp amplified fragment of exon 9 was digested into a 65 bp and 44 bp fragment by Taq 1 in genotypically unaffected individuals. The In summary, the Arg403Trp mutation in pedigree 106 was associated with a low penetrance rate on echocardiography as well as This family was treated as a single group when calculating the disease penetrance of the Arg249Gln mutation, as there were only two teenagers less than 16 years. The results, when evaluated by different criteria, were: 33% by echocardiography (using the strict criterion of ventricular wall thickness equal to or greater than 13 mm), 67% by echocardiography when taking into account all minor changes,29 50% by ECG (using the strict criterion of left ventricular hypertrophy), and 80% by ECG when including all changes compatible with hypertrophic cardiomyopathy.
Cardiac clinical events were rare in this family. The deceased obligate carrier died as a result of cancer of the larynx (aged 68 years). Not one single case of sudden cardiac death or syncope occurred, although three persons reported presyncopal attacks (III-14, IV-16, and IV-2 1). Eight of the 10 people were symptomatic, however, with chest pain and dyspnoea being the most frequent complaints. Both children were asymptomatic. Clinical examination showed abnormalities compatible with hypertrophic cardiomyopathy in four individuals. A family history revealed that individuals II-2 and II-3 died of respiratory disease, when aged >60 and >70 years respectively, while individual II-5 died at about 2 years of age of unknown causes.
In summary, the Arg249Gln mutation in this family was associated with a partial penetrance rate when assessed by echocardiography (using the strict criterion) but with a high penetrance rate when evaluated by ECG 
